CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 12.94: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.14%Below 5Y avg (0.43%)
Annual Rate
CNY 0.02Paid annual
Payout Ratio
2.5%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.95BCNY736.40M · vs all stocks (USD)
Trailing P/E
87.07xvs Medical Devices peers
Revenue (TTM)
549.93MCNY81.78M · vs all stocks (USD)
Profit Margin
10.43%vs Medical Devices peers
Beta
-0.0840xvs all stocks
52-Week Change
-31.31%vs all stocks
Market Capitalization
4.95BCNY736.40M · vs all stocks (USD)
Enterprise Value
4.28BCNY637.21M · vs all stocks (USD)
Trailing P/E
87.07xvs Medical Devices peers
Forward P/E
34.53xvs Medical Devices peers
Price to Sales (TTM)
8.71xvs Medical Devices peers
Price to Book (MRQ)
2.26xvs Medical Devices peers
Enterprise to Revenue
7.79xvs Medical Devices peers
Enterprise to EBITDA
61.56xvs Medical Devices peers
Gross Margin
72.78%vs Medical Devices peers
Profit Margin
10.43%vs Medical Devices peers
Operating Margin
5.75%vs Medical Devices peers
Return on Assets (TTM)
1.07%vs Medical Devices peers
Return on Equity (TTM)
1.74%vs Medical Devices peers
Revenue (TTM)
549.93MCNY81.78M · vs all stocks (USD)
Revenue per Share (TTM)
1.47CNYUpdated Aug 21, 2026Quarterly Revenue Growth
6.10%vs Medical Devices peers
Gross Profit (TTM)
391.23MCNY58.18M · vs all stocks (USD)
EBITDA (TTM)
65.12MCNY9.68M · vs all stocks (USD)
Net Income (TTM)
57.33MCNY8.53M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-45.00%vs Medical Devices peers
Operating Cash Flow (TTM)
60.80MCNY9.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-20.87MCNY-3.10M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0192CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.14%vs all stocks
5-Year Average Dividend Yield
0.43%vs all stocks
Payout Ratio
2.47%vs Medical Devices peers
Minority Interest (Equity)
20.00MCNYFY2025 · Dec 31, 2025Revenue
542.79MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
136.21MCNYFY2025 · Dec 31, 2025Gross Profit
406.58MCNYFY2025 · Dec 31, 2025Operating Income
80.71MCNY12.00M · vs all stocks (USD)
Pre-tax Income
55.20MCNYFY2025 · Dec 31, 2025Income Tax Expense
10.32MCNYFY2025 · Dec 31, 2025Net Income
44.89MCNYFY2025 · Dec 31, 2025EBIT
56.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
129.04MCNYFY2025 · Dec 31, 2025Research & Development
83.71MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
133.75MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.29MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1727CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1727CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
365.32MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
365.32MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
44.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
18.21MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-14.38MCNYFY2025 · Dec 31, 2025Free Cash Flow
-42.76MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
335.65MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
44.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.88MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-12.91MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-65.24MCNYFY2025 · Dec 31, 2025Capital Expenditures
-28.38MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.23BCNYFY2025 · Dec 31, 2025Sale of Investments
1.10BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-157.40MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
19.71MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-25.04MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-2.14MCNYFY2025 · Dec 31, 2025Other Financing Charges
26.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
18.61MCNYFY2025 · Dec 31, 2025Shares Outstanding
366.81MSharesUpdated Aug 21, 2026Float Shares
230.41MSharesUpdated Aug 21, 2026% Held by Insiders
40.42%vs all stocks
% Held by Institutions
11.49%vs all stocks
Total Cash (MRQ)
560.44MCNY83.34M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.53CNYUpdated Aug 21, 2026Total Debt (MRQ)
37.63MCNY5.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0176xvs Medical Devices peers
Current Ratio (MRQ)
5.85xvs Medical Devices peers
Book Value per Share (MRQ)
5.78CNYUpdated Aug 21, 2026Total Assets
2.38BCNY353.47M · vs all stocks (USD)
Total Current Assets
1.18BCNYFY2025 · Dec 31, 2025Total Liabilities
252.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.20BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
23.78MCNYFY2025 · Dec 31, 2025Total Current Liabilities
228.36MCNYFY2025 · Dec 31, 2025Cash
335.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
335.65MCNYFY2025 · Dec 31, 2025Other Short-term Investments
240.56MCNYFY2025 · Dec 31, 2025Accounts Receivable
96.73MCNYFY2025 · Dec 31, 2025Inventory
282.95MCNYFY2025 · Dec 31, 2025Accounts Payable
81.22MCNYFY2025 · Dec 31, 2025Short-term Debt
32.53MCNYFY2025 · Dec 31, 2025Other Current Liabilities
14.64MCNYFY2025 · Dec 31, 2025Long-term Debt
8.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
966.73KCNYFY2025 · Dec 31, 2025Common Stock (Book)
333.46MCNYFY2025 · Dec 31, 2025Retained Earnings
634.12MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.12BCNY315.98M · vs all stocks (USD)
52-Week Low
11.12CNYUpdated Aug 21, 202652-Week High
23.75CNYUpdated Aug 21, 202652-Week Change
-31.31%vs all stocks
Beta
-0.0840xvs all stocks
50-Day MA
12.68CNYUpdated Aug 21, 2026200-Day MA
16.16CNYUpdated Aug 21, 2026Avg 10-Day Volume
4.54MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.62MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1500CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 12.94: safe zoneNotable
Altman Z-Score: 12.94
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Yabao Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Biolight Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Immix Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Neurogene Inc.
Tier 1ProductionApproval-Gated PipelineRule
Monopar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
SS Innovations International, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Tibet Cheezheng Tibetan Medicine Co. Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated
Daoming Optics & Chemical Co., Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated
D.B. Corp Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated